Stock FULC FULCRUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Fulcrum Therapeutics, Inc.

Equities

FULC

US3596161097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
8.65 USD +6.27% Intraday chart for Fulcrum Therapeutics, Inc. +11.33% +28.15%
May. 20 Cantor Fitzgerald Initiates Fulcrum Therapeutics at Overweight Rating With $23 Price Target MT
May. 14 Oppenheimer Cuts Fulcrum Therapeutics Price Target to $14 From $16, Maintains Outperform Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. FULC Stock
  4. News Fulcrum Therapeutics, Inc.
  5. Official Publications